Spanish food company Natraceutical has bought UK rival Braes Group for €80m (US$102.1m) as the first step in its international expansion strategy which includes the acquisition of complementary businesses.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Valencia-based Natraceutical bought the firm from British private equity group 3i. It plans to finance the deal with its own cash flow and through an undisclosed share offer.
London-based Braes owns the Swiss-based biotech concerns Obipektin and Spreda as well as Overseal, a UK-based concern that makes sweetener Talin.
Natraceutical also named Xavier Adsera its new president, replacing Vicente Dominguez who resigned from the post. Natraceutical posted a 7.7% jump to €904,000 in first-quarter net profits on flat revenues of €5.8m, boosted by higher operating margins.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData
